| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.25▼ | 3.23▼ | 3.23▼ | 3.58▼ | 3.80▼ |
| MA10 | 3.25▼ | 3.29▼ | 3.29▼ | 3.76▼ | 3.79▼ |
| MA20 | 3.29▼ | 3.32▼ | 3.34▼ | 3.90▼ | 3.69▼ |
| MA50 | 3.34▼ | 3.61▼ | 3.72▼ | 3.82▼ | 4.20▼ |
| MA100 | 3.57▼ | 3.79▼ | 3.89▼ | 3.72▼ | 4.58▼ |
| MA200 | 3.78▼ | 3.90▼ | 3.89▼ | 4.14▼ | 3.18▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.008▲ | 0.009▲ | -0.095▼ | 0.036▲ |
| RSI | 40.336▼ | 39.490▼ | 39.267▼ | 35.068▼ | 39.504▼ |
| STOCH | 51.446 | 25.203 | 23.701 | 25.635 | 57.845 |
| WILL %R | -70.732 | -73.913 | -74.468 | -94.776▼ | -81.410▼ |
| CCI | -63.063 | -97.864 | -101.355▼ | -172.159▼ | -20.685 |
| CDL | $GALT Doji Candlestick Pattern Detected | Set Alert |
| ▼ BREAK | $GALT Price Breaks 10 Days Low | Set Alert |
| ▼ BREAK | $GALT Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $GALT Price Breaks 30 Days Low | Set Alert |
| ▼ GAP | $GALT Open Gap Down %2 | Set Alert |
| ▼ GAP | $GALT Open Gap Down %3 | Set Alert |
| ▼ GAP | $GALT Open Gap Down %5 | Set Alert |
| MA | $GALT Price Crossed Below MA(7) | Set Alert |
| MA | $GALT Price Crossed Below MA(13) | Set Alert |
| MA | $GALT Price Crossed Below MA(26) | Set Alert |
| MA | $GALT Price Crossed Below MA(50) | Set Alert |
| MA | $GALT Price Crossed Below MA(200) | Set Alert |
| ▼ MACD | $GALT MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| RSI | $GALT RSI(14) Crossed Below 50 | Set Alert |
|
Tuesday, November 12, 2019 04:00 AM
NORCROSS, Ga., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...
|
|
Monday, November 11, 2019 05:47 AM
NORCROSS, Ga., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Today, Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced a collaboration ...
|
|
Sunday, October 27, 2019 05:00 PM
So, the natural question for Galectin Therapeutics (NASDAQ:GALT) shareholders is whether they should be concerned by its rate of cash burn. For the purposes of this article, cash burn is the annual ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/11/19 | 3.35 | 3.39 | 3.16 | 3.23 | 327,600 |
| 14/11/19 | 3.36 | 3.42 | 3.27 | 3.37 | 311,500 |
| 13/11/19 | 3.57 | 3.61 | 3.19 | 3.39 | 529,800 |
| 12/11/19 | 4.13 | 4.20 | 3.56 | 3.59 | 1,043,800 |
| 11/11/19 | 3.92 | 4.50 | 3.91 | 4.32 | 1,136,100 |
| 08/11/19 | 3.94 | 3.99 | 3.90 | 3.97 | 65,600 |
| 07/11/19 | 3.87 | 3.97 | 3.82 | 3.94 | 114,100 |
| 06/11/19 | 3.92 | 3.96 | 3.85 | 3.86 | 76,500 |
| 05/11/19 | 4.04 | 4.04 | 3.88 | 3.92 | 136,496 |
| 04/11/19 | 4.02 | 4.05 | 3.96 | 3.98 | 117,680 |
|
|
||||
|
|
||||
|
|